Locations:
Lower toxicity than conventional chemo
Groundbreaking study paves way for targeted therapy
Rationale and status reports on mechanistically varied strategies
Gene signatures differentiate clinical response
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
10-year outcomes favor autologous over implant
Initial study results are encouraging
Higher doses don’t mean higher toxicity
New system better predicts patient outcomes
Improving outcomes with minimally invasive surgery
Minimally invasive staging technique improves accuracy, reduces complications
Advertisement
Advertisement
Search